Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HC Wainwright & Co. Maintains Buy on Uranium Royalty, Lowers Price Target to $4.5

Author: Benzinga Newsdesk | April 22, 2025 06:11am
HC Wainwright & Co. analyst Heiko Ihle maintains Uranium Royalty (NASDAQ:UROY) with a Buy and lowers the price target from $7.7 to $4.5.

Posted In: UROY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist